Zhitong Finance App News, Maike Pharmaceutical-B (02335.HK) issued an announcement. The phase II clinical trial of MT200605, a drug candidate developed independently by the Group to treat acute ischemic stroke, has completed database locking.

Zhitongcaijing · 3d ago
Zhitong Finance App News, Maike Pharmaceutical-B (02335.HK) issued an announcement. The phase II clinical trial of MT200605, a drug candidate developed independently by the Group to treat acute ischemic stroke, has completed database locking.